AI assistant
ANAPTYSBIO, INC — Director's Dealing 2023
Jan 11, 2023
32596_dirs_2023-01-10_8d5a96b5-ee44-4cac-a99c-65609a558278.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANAPTYSBIO, INC (ANAB)
CIK: 0001370053
Period of Report: 2023-01-06
Reporting Person: RENTON HOLLINGS (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-06 | Stock Option (right to buy) | $23.23 | A | 10600 | Acquired | 2033-01-05 | Common Stock (10600) | Direct |
| 2023-01-06 | Restricted Stock Unit | $ | A | 3900 | Acquired | Common Stock (3900) | Direct |
Footnotes
F1: The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
F2: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F3: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.